Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • gsk

    Tag: gsk

    You Searched For "gsk"
    Iconic Crocin Pain Relief to get a relaunch

    Iconic Crocin Pain Relief to get a relaunch

    Garima1 Nov 2019 1:49 PM IST
    GSK markets five varients of Crocin namely Crocin Advance, Crocin 650 Mg, Crocin Pain Relief, Crocin Cold & Flu and Crocin's Children Range...
    GSK Pharma reports Q2 profit at Rs 503 crore

    GSK Pharma reports Q2 profit at Rs 503 crore

    Medical Dialogues Bureau1 Nov 2019 9:15 AM IST
    GSK Pharmaceuticals continues to drive improved operational efficiencies reflecting in earnings before interest, tax, depreciation and amortisation...
    GSK lifts annual profit forecast after third quarter beat on vaccines strength

    GSK lifts annual profit forecast after third quarter beat on vaccines strength

    Medical Dialogues Bureau31 Oct 2019 9:00 AM IST
    GSK now expects full-year profit to be roughly flat compared to last year at constant currency, up from a previous forecast of a fall of 3% to 5%.New...
    GSK ovarian cancer drug Zejula gets USFDA nod for wider use

    GSK ovarian cancer drug Zejula gets USFDA nod for wider use

    Medical Dialogues Bureau24 Oct 2019 10:00 AM IST
    Zejula was the lead compound of U.S. cancer specialist Tesaro, which GSK acquired for $5.1 billion last year. Zejula brought in sales of 57 million...
    GSK to sell anti-rabies vaccines Rabipur, Encepur to Bavarian Nordic for USD 1.1 billion

    GSK to sell anti-rabies vaccines Rabipur, Encepur to Bavarian Nordic for USD 1.1 billion

    Medical Dialogues Bureau22 Oct 2019 10:00 AM IST
    The sale of GSK's anti-rabies treatment Rabipur and Encepur, used for the prevention of tick-borne encephalitis, to the Denmark-based biotechnology...
    GSK collaborates with Lyell Immunopharma on cancer cell therapies

    GSK collaborates with Lyell Immunopharma on cancer cell therapies

    Medical Dialogues Bureau12 Oct 2019 9:15 AM IST
    Combining GSK plc's strong cell and gene therapy programmes with Lyell's technologies may allow the joint research team to maximize the activity and...
    Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

    Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

    Medical Dialogues Bureau9 Oct 2019 9:30 AM IST
    GSK is recalling all unexpired stock of Zantac from pharmacies due to possible contamination with an impurity N-nitrosodimethylamine (NDMA), the...
    ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark

    ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark

    Farhat Nasim6 Oct 2019 11:10 AM IST
    New Delhi: In a relief to the pharmaceutical giant in a trademark matter, the Delhi High Court has recently restrained the manufacture or sale of...
    GSK decides to recall antacid Zinetac over safety concern

    GSK decides to recall antacid Zinetac over safety concern

    Medical Dialogues Bureau26 Sept 2019 4:54 PM IST
    New Delhi: GlaxoSmithKline Pharmaceuticals Ltd on Wednesday announced recall of ranitidine hydrochloride tablets produced in India using API sourced...
    CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

    CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

    Farhat Nasim25 Sept 2019 1:19 PM IST
    New Delhi: To ensure patient safety, the country's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO) has ordered an...
    GSK fights bid to strike new Zofran preemption evidence

    GSK fights bid to strike new Zofran preemption evidence

    Medical Dialogues Bureau20 Sept 2019 9:00 AM IST
    U.S. District Judge F. Dennis Saylor during a hearing in Boston asked why some of GSK's witnesses should be allowed to put forward new opinions to...
    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    Farhat Nasim19 Sept 2019 9:30 AM IST
    Johnson & Johnson (JnJ), GSK Plc's developmental partner, sell the over-the-counter nicotine oral spray in 45 countries, excluding the United...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok